A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection

Breast Cancer Research and Treatment

Volumn 139, Issue 1, 2013, Pages 125-134

  Kootstra, Jan J ^a   Dijkstra, Pieter U ^a   Rietman, Hans ^b,c   De Vries, Jaap ^a   Baas, Peter ^d   Geertzen, Jan H B ^a   Hoekstra, Harald J ^a   Hoekstra Weebers, Josette E H M ^a,e  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ROESSINGH RESEARCH AND DEVELOPMENT   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

^d MARTINI HOSPITAL   (Netherlands)

^e Integraal Kankercentrum Noord Nederland   (Netherlands)

Author keywords

Breast cancer; Longitudinal; Morbidity; Motion; Sentinel lymph node; Shoulder arm function

Indexed keywords

ANTINEOPLASTIC AGENT; TAMOXIFEN;

ABDUCTION; ADJUVANT THERAPY; ADULT; AGE; ARM DISEASE; ARM MOVEMENT; ARTICLE; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; FEMALE; FOLLOW UP; GRIP STRENGTH; HUMAN; JOINT MOBILITY; LONGITUDINAL STUDY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MORBIDITY; MUSCLE STRENGTH; PARTIAL MASTECTOMY; PHYSIOTHERAPY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RANGE OF MOTION; SENTINEL LYMPH NODE BIOPSY; SHOULDER DISEASE;

ARM; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LONGITUDINAL STUDIES; LYMPH NODE EXCISION; MUSCLE STRENGTH; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY; SHOULDER; SURVIVORS;

EID: 84877577884     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2509-y     Document Type: Article

References (49)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398
2. Krag DN, Weaver DL, Alex JC, Fairbank JT (1993) Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-339
3. Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720
4. Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881-888
5. Mansel RE, Fallowfield LJ, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599-609
6. Wilke LG, McCall LM, Posther KE et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13:491-500
7. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23-27
8. Del Bianco P, Zavagno G, Burelli P et al (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34:508-513
9. Haid A, Kuehn T, Konstantiniuk P, Köberle-Wührer R, Knauer M, Keienberg R, Zimmermann G (2002) Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28:705-710
10. Husted Madsen A, Haugaard K, Soerensen J, Bokmand S, Friis E, Holtveg H, Peter Garne J, Horby J, Cristiansen P (2008) Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast 17:138-147
11. Langer I, Guller U, Berclaz G et al (2007) Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245:452-461
12. Leidenius M, Leppänen E, Krogerus L, von Smitten K (2003) Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185:127-130
13. Leidenius M, Leivonen M, Vironen J, von Smitten K (2005) The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92:23-31
14. Peintinger F, Reitsamer R, Stranzl H, Ralph G (2003) Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89:648-652
15. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, Duffy SW (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23:4312-4321
16. Ronka R, von Smitten K, Tasmuth T, Leidenius M (2005) One-year morbidity after sentinel node biopsy and breast surgery. Breast 14:28-36
17. Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614
18. Temple LK, Baron R, Cody HS III et al (2002) Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9:654-662
19. Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546-553
20. Zavagno G, De Salvo GL, Scalco G et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247:207-213
21. Haid A, Köberle-Wührer R, Knauer M et al (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31-36
22. Arnaud S, Houvenaeghel G, Moutardier V et al (2004) Patients' and surgeons' perspectives on axillary surgery for breast cancer. Eur J Surg Oncol 30:735-743
23. Kootstra J, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas PC, Geertzen JH, Hoekstra HJ (2008) Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol 15:2533-2541
24. Rietman JS, Geertzen JH, Hoekstra HJ, Baas PC, Dolsma WV, de Vries J, Groothoff JW, Eisma WH, Dijkstra PU (2006) Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32:148-152
25. Rietman JS, Dijkstra PU, Geertzen JH, Baas PC, de Vries J, Dolsma WV, Groothoff JW, Eisma WH, Hoekstra HJ (2004) Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11:1018-1024
26. Kootstra JJ, Hoekstra-Weebers JE, Rietman H, de Vries J, Baas PC, Geertzen JH, Hoekstra HJ (2010) A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection. Ann Surg Oncol 17:2384-2394
27. Helms G, Kühn T, Moser L, Remmel E, Kreienberg R (2009) Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection - data from a prospective randomised trial. Eur J Surg Oncol 35:696-701
28. Ashikga T, Krag DN, Land SR, Julian TB, Anderson SJ, Brown AM, Skelly JM, Harlow SP, Weaver DL, Mamounas EP, Costantino JP, Wolmark N (2010) Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 102:111-118
29. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A (2006) Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93:109-119
30. Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE (2008) Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 15:1996-2005
31. McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213-5219
32. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM (2002) Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9:745-753
33. Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, Shieh C, Morehead-Gee A, Gerber LH, Stout NL (2012) Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery. Breast Cancer Res Treat 134:315-324
34. http://apps.who.int/classifications/icfbrowser/. Accessed 7 March 2013
35. Rutgers EJ, Jansen L, Nieweg OE, de Vries J, Schraffordt KH, Kroon BB (1998) Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol 24:316-319
36. http://www.oncoline.nl. Accessed 21 June 2012
37. Green S, Buchbinder R, Forbes A, Bellamy N (1998) A standardized protocol for measurement of range of movement of the shoulder using the Plurimeter-V inclinometer and assessment of its intrarater and interrater reliability. Arthritis Care Res 11:43-52
38. van der Ploeg RJ, Fidler V, Oosterhuis HJ (1991) Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry 54:244-247
39. Mathiowetz V, Weber K, Volland G, Kashman N (1984) Reliability and validity of grip and pinch strength evaluations. J Hand Surg (Am) 9:222-226
40. Swedborg I, Borg G, Sarnelid M (1981) Somatic sensation and discomfort in the arm of post-mastectomy patients. Scand J Rehabil Med 13:23-29
41. Sitzia J (1995) Volume measurement in lymphoedema treatment: examination of formulae. Eur J Cancer Care (Engl) 4:11-16
42. Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA (2003) Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 90:76-81
43. Pain SJ, Purushotham AD (2000) Lymphoedema following surgery for breast cancer. Br J Surg 87:1128-1141
44. Wernicke AG, Goodman RL, Turner BC, Komarnicky LT, Curran WJ, Christos PJ, Khan I, Vandris K, Parashar B, Nori D, Chao KSC (2011) A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance. Breast Cancer Res Treat 125:893-902
45. Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368-1377
46. Husen M, Paaschburg B, Flyger HL (2006) Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 15:620-628
47. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95(3):279-293
48. Yap KP, McCready DR, Narod S, Manchul LA, Trudeau M, Fyles A (2003) Factors influencing arm and axillary symptoms after treatment for node negative breast carcinoma. Cancer 97(6):1369-1375
49. Albert US, Koller M, Kopp I, Lorenz W, Schulz KD, Wagner U (2006) Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study. Breast Cancer Res Treat 100(3):285-292